Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for IART.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 3.578B
December 31, 2025 3.602B
September 30, 2025 3.646B
June 30, 2025 3.668B
March 31, 2025 4.053B
December 31, 2024 4.037B
September 30, 2024 4.066B
June 30, 2024 4.074B
March 31, 2024 4.078B
December 31, 2023 3.782B
September 30, 2023 3.739B
June 30, 2023 3.778B
March 31, 2023 3.742B
December 31, 2022 3.890B
September 30, 2022 3.807B
June 30, 2022 3.753B
March 31, 2022 3.672B
December 31, 2021 3.782B
September 30, 2021 3.774B
June 30, 2021 3.713B
March 31, 2021 3.742B
December 31, 2020 3.615B
September 30, 2020 3.454B
June 30, 2020 3.392B
March 31, 2020 3.448B
Date Value
December 31, 2019 3.303B
September 30, 2019 3.347B
June 30, 2019 3.290B
March 31, 2019 3.206B
December 31, 2018 3.108B
September 30, 2018 3.179B
June 30, 2018 3.186B
March 31, 2018 3.248B
December 31, 2017 3.211B
September 30, 2017 2.418B
June 30, 2017 2.101B
March 31, 2017 2.049B
December 31, 2016 1.808B
September 30, 2016 1.827B
June 30, 2016 1.814B
March 31, 2016 1.830B
December 31, 2015 1.775B
September 30, 2015 1.828B
June 30, 2015 1.638B
March 31, 2015 1.551B
December 31, 2014 1.579B
September 30, 2014 1.546B
June 30, 2014 1.563B
March 31, 2014 1.556B
December 31, 2013 1.196B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
CONMED Corp. 2.315B
Haemonetics Corp. 2.396B
IDEXX Laboratories, Inc. 3.385B
Globus Medical, Inc. 5.440B
Boston Scientific Corp. 44.35B

Total Assets (Quarterly) Related Metrics